These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 18714306)
1. Phase I study of noninvasive imaging of adenovirus-mediated gene expression in the human prostate. Barton KN; Stricker H; Brown SL; Elshaikh M; Aref I; Lu M; Pegg J; Zhang Y; Karvelis KC; Siddiqui F; Kim JH; Freytag SO; Movsas B Mol Ther; 2008 Oct; 16(10):1761-9. PubMed ID: 18714306 [TBL] [Abstract][Full Text] [Related]
2. Feasibility of adenovirus-mediated hNIS gene transfer and 131I radioiodine therapy as a definitive treatment for localized prostate cancer. Barton KN; Stricker H; Elshaikh MA; Pegg J; Cheng J; Zhang Y; Karvelis KC; Lu M; Movsas B; Freytag SO Mol Ther; 2011 Jul; 19(7):1353-9. PubMed ID: 21587209 [TBL] [Abstract][Full Text] [Related]
3. GENIS: gene expression of sodium iodide symporter for noninvasive imaging of gene therapy vectors and quantification of gene expression in vivo. Barton KN; Tyson D; Stricker H; Lew YS; Heisey G; Koul S; de la Zerda A; Yin FF; Yan H; Nagaraja TN; Randall KA; Jin GK; Fenstermacher JD; Jhiang S; Ho Kim J; Freytag SO; Brown SL Mol Ther; 2003 Sep; 8(3):508-18. PubMed ID: 12946325 [TBL] [Abstract][Full Text] [Related]
4. Design considerations for incorporating sodium iodide symporter reporter gene imaging into prostate cancer gene therapy trials. Siddiqui F; Barton KN; Stricker HJ; Steyn PF; Larue SM; Karvelis KC; Sparks RB; Kim JH; Brown SL; Freytag SO Hum Gene Ther; 2007 Apr; 18(4):312-22. PubMed ID: 17408358 [TBL] [Abstract][Full Text] [Related]
5. Replication-competent adenovirus-mediated suicide gene therapy with radiation in a preclinical model of pancreatic cancer. Freytag SO; Barton KN; Brown SL; Narra V; Zhang Y; Tyson D; Nall C; Lu M; Ajlouni M; Movsas B; Kim JH Mol Ther; 2007 Sep; 15(9):1600-6. PubMed ID: 17551507 [TBL] [Abstract][Full Text] [Related]
6. Second-generation replication-competent oncolytic adenovirus armed with improved suicide genes and ADP gene demonstrates greater efficacy without increased toxicity. Barton KN; Paielli D; Zhang Y; Koul S; Brown SL; Lu M; Seely J; Kim JH; Freytag SO Mol Ther; 2006 Feb; 13(2):347-56. PubMed ID: 16290236 [TBL] [Abstract][Full Text] [Related]
7. Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate cancer. Freytag SO; Stricker H; Pegg J; Paielli D; Pradhan DG; Peabody J; DePeralta-Venturina M; Xia X; Brown S; Lu M; Kim JH Cancer Res; 2003 Nov; 63(21):7497-506. PubMed ID: 14612551 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the biodistribution, persistence, toxicity, and potential of germ-line transmission of a replication-competent human adenovirus following intraprostatic administration in the mouse. Paielli DL; Wing MS; Rogulski KR; Gilbert JD; Kolozsvary A; Kim JH; Hughes J; Schnell M; Thompson T; Freytag SO Mol Ther; 2000 Mar; 1(3):263-74. PubMed ID: 10933942 [TBL] [Abstract][Full Text] [Related]
9. Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer. Freytag SO; Khil M; Stricker H; Peabody J; Menon M; DePeralta-Venturina M; Nafziger D; Pegg J; Paielli D; Brown S; Barton K; Lu M; Aguilar-Cordova E; Kim JH Cancer Res; 2002 Sep; 62(17):4968-76. PubMed ID: 12208748 [TBL] [Abstract][Full Text] [Related]
10. Systemic image-guided liver cancer radiovirotherapy using dendrimer-coated adenovirus encoding the sodium iodide symporter as theranostic gene. Grünwald GK; Vetter A; Klutz K; Willhauck MJ; Schwenk N; Senekowitsch-Schmidtke R; Schwaiger M; Zach C; Wagner E; Göke B; Holm PS; Ogris M; Spitzweg C J Nucl Med; 2013 Aug; 54(8):1450-7. PubMed ID: 23843567 [TBL] [Abstract][Full Text] [Related]
11. Adaptive seamless design for an efficacy trial of replication-competent adenovirus-mediated suicide gene therapy and radiation in newly-diagnosed prostate cancer (ReCAP Trial). Lu M; Freytag SO; Stricker H; Kim JH; Barton K; Movsas B Contemp Clin Trials; 2011 May; 32(3):453-60. PubMed ID: 21300181 [TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated expression of human sodium-iodide symporter gene permits in vivo tracking of adipose tissue-derived stem cells in a canine myocardial infarction model. Lee AR; Woo SK; Kang SK; Lee SY; Lee MY; Park NW; Song SH; Lee SY; Nahm SS; Yu JE; Kim MH; Yoo RJ; Kang JH; Lee YJ; Eom KD Nucl Med Biol; 2015 Jul; 42(7):621-9. PubMed ID: 25899941 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and toxicity of replication-competent adenovirus-mediated double suicide gene therapy in combination with radiation therapy in an orthotopic mouse prostate cancer model. Freytag SO; Paielli D; Wing M; Rogulski K; Brown S; Kolozsvary A; Seely J; Barton K; Dragovic A; Kim JH Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):873-85. PubMed ID: 12377341 [TBL] [Abstract][Full Text] [Related]
14. A preclinical large animal model of adenovirus-mediated expression of the sodium-iodide symporter for radioiodide imaging and therapy of locally recurrent prostate cancer. Dwyer RM; Schatz SM; Bergert ER; Myers RM; Harvey ME; Classic KL; Blanco MC; Frisk CS; Marler RJ; Davis BJ; O'Connor MK; Russell SJ; Morris JC Mol Ther; 2005 Nov; 12(5):835-41. PubMed ID: 16054438 [TBL] [Abstract][Full Text] [Related]
15. In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial. Herman JR; Adler HL; Aguilar-Cordova E; Rojas-Martinez A; Woo S; Timme TL; Wheeler TM; Thompson TC; Scardino PT Hum Gene Ther; 1999 May; 10(7):1239-49. PubMed ID: 10340555 [TBL] [Abstract][Full Text] [Related]
16. Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer. Kakinuma H; Bergert ER; Spitzweg C; Cheville JC; Lieber MM; Morris JC Cancer Res; 2003 Nov; 63(22):7840-4. PubMed ID: 14633711 [TBL] [Abstract][Full Text] [Related]
17. Virus specific immune responses after human neoadjuvant adenovirus-mediated suicide gene therapy for prostate cancer. van der Linden RR; Haagmans BL; Mongiat-Artus P; van Doornum GJ; Kraaij R; Kadmon D; Aguilar-Cordova E; Osterhaus AD; van der Kwast TH; Bangma CH Eur Urol; 2005 Jul; 48(1):153-61. PubMed ID: 15967266 [TBL] [Abstract][Full Text] [Related]
18. A model for optimizing adenoviral delivery in human cancer gene therapy trials. Barton KN; Freytag SO; Nurushev T; Yoo S; Lu M; Yin FF; Li S; Movsas B; Kim JH; Brown SL Hum Gene Ther; 2007 Jun; 18(6):562-72. PubMed ID: 17594241 [TBL] [Abstract][Full Text] [Related]
19. Adenovirus biodistribution and noninvasive imaging of gene expression in vivo by positron emission tomography using human sodium/iodide symporter as reporter gene. Groot-Wassink T; Aboagye EO; Glaser M; Lemoine NR; Vassaux G Hum Gene Ther; 2002 Sep; 13(14):1723-35. PubMed ID: 12396625 [TBL] [Abstract][Full Text] [Related]
20. Noninvasive In Vivo Quantification of Adeno-Associated Virus Serotype 9-Mediated Expression of the Sodium/Iodide Symporter Under Hindlimb Ischemia and Neuraminidase Desialylation in Skeletal Muscle Using Single-Photon Emission Computed Tomography/Computed Tomography. Boutagy NE; Ravera S; Papademetris X; Onofrey JA; Zhuang ZW; Wu J; Feher A; Stacy MR; French BA; Annex BH; Carrasco N; Sinusas AJ Circ Cardiovasc Imaging; 2019 Jul; 12(7):e009063. PubMed ID: 31296047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]